Combined vaccination with quadrivalent influenza vaccine and 23-valent pneumococcal polysaccharide vaccine
PRO-INF4-MA4002-JStz
Approved mab completed
Quick answer
Combined vaccination with quadrivalent influenza vaccine and 23-valent pneumococcal polysaccharide vaccine for Influenza and Pneumonia is a Approved program (mab) at SINOVAC BIOTECH LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SINOVAC BIOTECH LTD
- Indication
- Influenza and Pneumonia
- Phase
- Approved
- Modality
- mab
- Status
- completed